Forbes March 10, 2023
Bill Frist

This is the fourth and final installment for my series on the Health Affairs Council on Health Care Spending and Value’s February 2023 report, “A Road Map for Action.” Each piece details one of the four priority areas within the report, which include recommendations on how the U.S. can take a more deliberate approach to moderating health care spending growth while maximizing value. I served as co-chair of this initiative, along with former FDA Commissioner Dr. Margaret Hamburg. This final piece outlines our recommended actions on value-based payment. Click here to read Part I, Part II and Part III.

Over the past few years, the health care sector has undergone a cultural shift toward not only prioritizing better value and...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Employer, Govt Agencies, Healthcare System, Insurance, Medical Devices, Patient / Consumer, Payment Models, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Survey / Study, Trends, Value Based
What Fishing Can Teach Us About Lowering Healthcare Costs
Drug Expenditures Surge. Drug Prices Don't.
Weight-Loss Drugs Drive U.S. Prescription Spending
Why Are Cash Prices Lower Than Health Insurance Negotiated Prices?
STAT+: Hospital price transparency rules are seeding a new crop of health tech startups

Share This Article